| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 10/26/2006 | WO2006111858A2 Bis-(coumarin) compounds with anti-inflammatory activity |
| 10/26/2006 | WO2006111662A2 4h-1,2,4-triazin-5-one derivatives, their preparation and their use as alpha 7 nicotinic acetylcholine receptors |
| 10/26/2006 | WO2006111371A1 Pharmaceutically active diazepanes |
| 10/26/2006 | WO2006094237A3 Acridine and quinoline dervatives as sirtuin modulators |
| 10/26/2006 | WO2006090268A3 Processes for the preparation of alfuzosin and salts thereof and novel crystalline forms of alfuzosin |
| 10/26/2006 | WO2006083271A3 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication |
| 10/26/2006 | WO2006036941A3 Specific kinase inhibitors |
| 10/26/2006 | WO2005105778A3 4-amino-5-cyanopyrimidine derivatives |
| 10/26/2006 | WO2005095384A8 Pyrazine derivatives and pharmaceutical use thereof as adenosine antagonists |
| 10/26/2006 | US20060241259 for photopolymerization; photography, relief imaging; color filters |
| 10/26/2006 | US20060241171 Novel physiologically active substances |
| 10/26/2006 | US20060241168 administering a protein kinase B activating agent comprising (R)-5,6-dimethoxy-2-[2,2,4,6,7-pentamethyl-3-(4-methylphenyl)-2,3-dihydro-1-benzofuran-5-yl]isoindoline; treating depression, posttraumatic stress disorder, Parkinson's disease, Alzheimer's diseases |
| 10/26/2006 | US20060241155 TNF-alpha production inhibitors |
| 10/26/2006 | US20060241147 Pyridine derivatives useful for inhibiting sodium/calcium exchange system |
| 10/26/2006 | US20060241146 2-cyano-1-[t-4-(4-acetyl-1-piperazinyl)-1-methyl-r-1-cyclohexylamino]acetylpyrrolidine; dipeptidylpeptidase IV (DPPIV) inhibitor; antidiabetic, insulin resistance, hyperglycemia, obesity; antiproliferative agent for T-cell, HIV, AIDS; arthritis, osteoporosis |
| 10/26/2006 | US20060241137 Triazole compounds and the therapeutic use thereof |
| 10/26/2006 | US20060241126 Phospholipase inhibitors perticularly phospholipase A2 enzyme Lipoprotein Associated Phospholipase A2; N-(1-Methylpiperidin-4-yl)-(2-(2-(2,3-difluorophenyl)ethyl)-4-oxo-4H-pyrido[2,3-d]pyrimidin-1-yl)-N-(4-(4-trifluoromethylphenyl)phenyl)methylacetamide; amidation |
| 10/26/2006 | US20060241123 Substituted piperidine and piperazine derivatives as melanocortin-4 receptor modulators |
| 10/26/2006 | US20060241119 Thio-substituted tricyclic and bicyclic aromatic methanesulfinyl derivatives |
| 10/26/2006 | US20060241115 2,3-Dihydro-4H-1,4-benzoxazine derivatives containing an optionally fused pyridine or pyrimidine ring; 7-((6,7-bis(methyloxy)-4-quinolinyl)oxy)-N-phenyl-2,3-dihydro-4H-1,4-benzoxazine-4-carboxamide; kinase inhibitors; inflammation, angiogenesis and cancer |
| 10/26/2006 | US20060241111 inhibitors of coagulation factor Xa such as 1-(5-chlorothien-2-ylcarbonyl)-4-[4-(3-oxomorpholin-4-yl)phenyl]-2-propylsemicarbazide, used for preventing thrombosis, infarction, arteriosclerosis, inflammation, bleeding, angina pectoris, restenosis, intermittent claudication and treatment of tumors |
| 10/26/2006 | US20060241110 2-(Imidazol-1-ylalkyl)-3H-quinazolin-4-one derivatives; mitotic kinesin KSP inhibitors; anticarcinogenic, antiinflammatory, and antiproliferative agents |
| 10/26/2006 | US20060241105 To control arthropods (including insects and arachnids) and helminths (including nematodes) also valuable to protect timber from sawflies, beetles or termites or use in veterinary medicine; 1-(2,6-Dichloro-4-trifluoromethylphenyl)-3-(N-benzyloxy-2-amidino)-5-methylamino-4-trifluoromethylsulfonylpyrazole |
| 10/26/2006 | US20060241103 Inhibiting polymerization of FtsZ in a bacterium by contactng with 2,3-diphenyl-6-(ethoxycarbonylamino)-8-(4-(diethylamino)-1-methylbutylamino)pyrido[2,3-b]pyrazine, optionally linked to a permeability enhancer to allow the compound to cross the bacterium's cell envelope |
| 10/26/2006 | US20060240048 Pyridine derivatives as cb2 receptor modulators |
| 10/26/2006 | US20060239927 Drug for airway administration |
| 10/26/2006 | DE102005018026A1 New substituted styrol stereoisomers are glucocorticoid receptor ligands useful for the treatment of e.g. inflammatory diseases, lung diseases, rheumatic diseases, autoimmune diseases, joint disorders and gastrointestinal disorders |
| 10/26/2006 | CA2610446A1 Nitrogen-containing heterocyclic compound |
| 10/26/2006 | CA2606288A1 Subtituted heteroaryl cb1 antagonists |
| 10/26/2006 | CA2605059A1 Oxindole compounds and their uses as therapeutic agents |
| 10/26/2006 | CA2604920A1 Novel compounds useful for bradykinin b1 receptor antagonism |
| 10/26/2006 | CA2602610A1 Benzimidazole compound |
| 10/26/2006 | CA2601979A1 2,3 substituted pyrazine sulfonamides |
| 10/26/2006 | CA2600774A1 Pharmaceutically active diazepanes |
| 10/25/2006 | EP1713823A2 Hcv ns-3 serine protease inhibitors |
| 10/25/2006 | EP1713822A2 Hcv ns-3 serine protease inhibitors |
| 10/25/2006 | EP1713797A1 1-ISOPROPYL-2-OXO-1,2-DIHYDROPYRIDINE-3-CARBOXAMIDE DERIVATIVES HAVING 5-HT sb 4 /sb RECEPTOR AGONISTIC ACTIVITY |
| 10/25/2006 | EP1713796A1 Process for preparing substituted benzopyran compounds |
| 10/25/2006 | EP1713790A2 Method of preparation of benzofuran-2-carboxylic acid (s)-3-methyl-1- ((4s, 7r)-7methyl-3-oxo-1-(pyridine-2-sulfonyl)-az epan-4-ylcarbamoyl-butyl)-amide |
| 10/25/2006 | EP1713782A1 Pth agonists |
| 10/25/2006 | EP1713780A2 Novel inhibitors of glutaminyl cyclase |
| 10/25/2006 | EP1713778A1 Benzazepine derivatives as histamine h3 antagonists |
| 10/25/2006 | EP1713484A2 Compounds and methods of use |
| 10/25/2006 | EP1590346B1 4- {'3-(sulfonylamino) phenyl] '1-(cyclymethyl) piperidin-4-ylidene] methyl} benazmide derivatives as delta opioid receptor ligands for the treatment of pain, anxiety and functional gastrointestinal disorder |
| 10/25/2006 | EP1554272B1 Benzimidazoles and benzothiazoles as inhibitors of map kinase |
| 10/25/2006 | EP1409525B1 Human papillomavirus e2 transactivation domain/inhibitor co-crystal and x-ray coordinates defining the inhibitor-binding pocket |
| 10/25/2006 | EP1265606B1 Cell adhesion inhibitors |
| 10/25/2006 | EP1089998B1 Epothilone derivatives and their synthesis and use |
| 10/25/2006 | EP1016866B1 Novel compound 2-amino-3-[2-(alpha-mannopyranosyl) indol-3-yl] propionic acid, process for preparing the same, and method for inspecting function of living body with the novel compound |
| 10/25/2006 | CN1852906A Novel compounds |
| 10/25/2006 | CN1852905A N-substituted benzimidazolyl c-kit inhibitors |
| 10/25/2006 | CN1852900A 2,4-di (phenylamino) pyrimidines useful in the treatment of proliferative disorders |
| 10/25/2006 | CN1852897A Gabanergic modulators |
| 10/25/2006 | CN1852896A Quinoline and quinazoline derivatives having affinity for 5HT1-type receptors |
| 10/25/2006 | CN1852710A Pyrazolines as PAR-1 antagonists for treatment of cardiovascular diseases |
| 10/25/2006 | CN1850820A Coumarin derivatives, and their preparing method and use as alpha, receptor agonist |
| 10/25/2006 | CN1281604C Substituted pyrazole compounds |
| 10/25/2006 | CN1281598C Compounds and methods for modulation of estrogen receptors |
| 10/25/2006 | CN1281597C New compounds, which are potent inhibitors of Na<+>/Ca<2+> exchange mechanism and are useful in the treatment of arrhythmias |
| 10/25/2006 | CN1281585C Cyclic diamine compounds having fused-ring groups |
| 10/24/2006 | US7126012 Has affinity for melatonin receptors and/or selectivity for melatoninergic receptors; antiinflammatory and anticarcinogic agents |
| 10/24/2006 | US7126010 Benzylcycloalkyl amines as modulators of chemokine receptor activity |
| 10/24/2006 | US7125997 Differential tumor cytotoxicity compounds and compositions |
| 10/24/2006 | US7125996 Fluorescent probes for use in protein kinase inhibitor binding assay |
| 10/24/2006 | US7125995 Substituted amidoalkyl uracils and their use as inhibitors of the poly(adp-ribose) synthetase (PARS) |
| 10/24/2006 | US7125994 PNA monomer and precursor |
| 10/24/2006 | US7125904 Cardiovascular disorders; hypotensive agents; congestive heart failure |
| 10/24/2006 | US7125898 Kinase inhibitors to mediate disease and as antiinflammatory agents |
| 10/24/2006 | US7125895 Arylalkylamine compounds as chemokine receptor antagonists for therapy and prevention of diseases such as arthritis or rheumatic diseases |
| 10/24/2006 | US7125893 Compounds useful for treatment of tumors or cancer of the stomach, colon, neck or used in angiogenesis and forming the compound with cyclization |
| 10/24/2006 | US7125892 Aryl aniline β2 adrenergic receptor agonists |
| 10/24/2006 | US7125887 Pyrrolidine modulators of CCR5 chemokine receptor activity |
| 10/24/2006 | US7125883 alpha v beta 3 integrin receptor modulators; treating variety of diseases including cardiovascular disorders, retinopathy, strokes, cancer, osteoporosis, tumor metastasis, high blood pressure, psoriasis, antiviral, antimycotic, antiparasitic or antibacterial therapy; 1,2-dihydropyrimidin-2-one moiety |
| 10/24/2006 | US7125881 Use of pyrimidine—or triazine—2 carbonitiles for treating diseases associated with cysteine prostease activity and novel pyrimidine-2-carbonitile derivatives |
| 10/24/2006 | US7125879 Prevention reproduction of virus |
| 10/24/2006 | US7125877 Brain disorders; psychological disorders; central nervous system disorders; antidiabetic agents; hypotensive agents |
| 10/24/2006 | CA2261848C Cell adhesion inhibitors |
| 10/24/2006 | CA2249402C Benzopyran derivatives having leukotriene-antagonistic action |
| 10/24/2006 | CA2246678C Substituted 2-aryl-1,2,4-triazine-3,5-di(thi)ones as herbicides |
| 10/24/2006 | CA2223094C Phenylpyridazinones |
| 10/24/2006 | CA2214752C Herbicidal or fungicidal sulphonylaminocarbonyltriazolinones with halogenated alk(en)oxy substituents |
| 10/24/2006 | CA2211411C Sulphonyl amino(thio)carbonyl-1,2,4-triazolin(thi)one derivatives, the production thereof and the use thereof as herbicides |
| 10/24/2006 | CA2195663C Dihydrobenzofuranes |
| 10/24/2006 | CA2168023C Vasoconstrictive substituted aryloxyalkyl diamines |
| 10/19/2006 | WO2006110804A2 Synthesis of nitrodibenzylfuran chromophore for photodeprotection of organic molecules |
| 10/19/2006 | WO2006110476A2 Cytotoxic compounds and conjugates comprising duocarmycins with cleavable substrates |
| 10/19/2006 | WO2006109846A1 Triazole derivative and the use thereof |
| 10/19/2006 | WO2006109084A1 Dna-pk inhibitors |
| 10/19/2006 | WO2006109081A1 Dna-pk inhibitors |
| 10/19/2006 | WO2006108837A1 Aminoalkyl-amidomethyl-substituted 2- (4-sulphonylamino) -3-hydroxy-3 , 4-dihydro-2h-cromen-6-yl derivatives and their use as potassium channel blockers |
| 10/19/2006 | WO2006108791A2 Heterocyclylethylheterocyclylcarboxamide derivatives as fungicides |
| 10/19/2006 | WO2006108699A1 Indazoles as glucocorticoid receptor ligands |
| 10/19/2006 | WO2006108591A1 1h-quinaz0line-2,4-diones and their use as ampa-receptor ligands |
| 10/19/2006 | WO2006050476A3 Pyrimidine derivatives as ion channel modulators and methods of use |
| 10/19/2006 | WO2005103041A3 Treatment of cns disorders using cns target modulators |
| 10/19/2006 | US20060235225 Having a diffraction peak at a diffraction angle (2 theta +-0.2 degrees ) of 12.8 degrees, 18.1 degrees and/or 23.5 degrees in a powder X-ray diffraction; stable against exposure to light |
| 10/19/2006 | US20060235222 Indole-derivative modulators of steroid hormone nuclear receptors |
| 10/19/2006 | US20060235054 e.g. 3-substituted 5-(4-fluorophenyl)-4-(4-pyridyl)imidazole-2-thione; immunomodulating and cytokine-release-inhibiting action; antiinflammatory agent |
| 10/19/2006 | US20060235032 Substituted quinazolines as antiviral agents, especially against cytomegaloviruses |
| 10/19/2006 | US20060235024 Acetylinic piperazine compounds and their use as metabotropic glutamate receptor antagonists |